Sensitive on-site detection of SARS-CoV-2 by ID NOW COVID-19
- PMID: 33971264
- PMCID: PMC8105142
- DOI: 10.1016/j.mcp.2021.101742
Sensitive on-site detection of SARS-CoV-2 by ID NOW COVID-19
Abstract
Point of care detection of SARS-CoV-2 is one pillar in a containment strategy and important to break infection chains. Here we report the sensitive, specific and robust detection of SARS-CoV-2 and respective variants of concern by the ID NOW COVID-19 device.
Keywords: COVID-19; Diagnostics; On-site detection; SARS CoV-2.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
The authors declare that they have no known competing interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures


Similar articles
-
Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting.Pathology. 2021 Dec;53(7):912-914. doi: 10.1016/j.pathol.2021.07.002. Epub 2021 Sep 4. Pathology. 2021. PMID: 34561096 Free PMC article. No abstract available.
-
COVID-19 and Diagnostic Testing for SARS-CoV-2 by RT-qPCR-Facts and Fallacies.Int J Mol Sci. 2021 Feb 28;22(5):2459. doi: 10.3390/ijms22052459. Int J Mol Sci. 2021. PMID: 33671091 Free PMC article.
-
Development and validation of a new triplex real-time quantitative reverse Transcriptase-PCR assay for the clinical detection of SARS-CoV-2.Mol Cell Probes. 2021 Aug;58:101744. doi: 10.1016/j.mcp.2021.101744. Epub 2021 Jun 4. Mol Cell Probes. 2021. PMID: 34089805 Free PMC article.
-
Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.J Med Virol. 2021 Jul;93(7):4523-4531. doi: 10.1002/jmv.26994. Epub 2021 May 3. J Med Virol. 2021. PMID: 33913533 Free PMC article.
-
Isothermal SARS-CoV-2 Diagnostics: Tools for Enabling Distributed Pandemic Testing as a Means of Supporting Safe Reopenings.ACS Synth Biol. 2020 Nov 20;9(11):2861-2880. doi: 10.1021/acssynbio.0c00359. Epub 2020 Oct 9. ACS Synth Biol. 2020. PMID: 32966744 Review.
Cited by
-
"It Was Very Comforting to Find Out Right Away." - Patient Perspectives on Point-of-Care Molecular SARS-CoV-2 Testing in Primary Care.Patient Prefer Adherence. 2022 Aug 10;16:2031-2039. doi: 10.2147/PPA.S372366. eCollection 2022. Patient Prefer Adherence. 2022. PMID: 35975172 Free PMC article.
-
Micro/nano biomedical devices for point-of-care diagnosis of infectious respiratory diseases.Med Nov Technol Devices. 2022 Jun;14:100116. doi: 10.1016/j.medntd.2022.100116. Epub 2022 Feb 12. Med Nov Technol Devices. 2022. PMID: 35187465 Free PMC article. Review.
-
Perspectives of physicians and medical assistants on the implementation of NAAT-based point-of-care testing for SARS-CoV-2 in primary care in Germany.Z Evid Fortbild Qual Gesundhwes. 2022 Dec;175:43-49. doi: 10.1016/j.zefq.2022.09.006. Epub 2022 Nov 10. Z Evid Fortbild Qual Gesundhwes. 2022. PMID: 36372644 Free PMC article.
References
-
- WHO/WHE/2021.02, COVID-19 Strategic Preparedness and Response Plan. SPRP 2021; 2021.
-
- Chu D.K.W., Pan Y., Cheng S.M.S., Hui K.P.Y., Krishnan P., Liu Y., Ng D.Y.M., Wan C.K.C., Yang P., Wang Q., Peiris M., Poon L.L.M. Molecular diagnosis of a novel coronavirus (2019-nCoV) causing an outbreak of pneumonia. Clin. Chem. 2020;66:549–555. doi: 10.1093/clinchem/hvaa029. - DOI - PMC - PubMed
-
- Corman V.M., Landt O., Kaiser M., Molenkamp R., Meijer A., Chu D.K.W., Bleicker T., Brünink S., Schneider J., Schmidt M.L., Mulders D.G.J.C., Haagmans B.L., Van Der Veer B., Van Den Brink S., Wijsman L., Goderski G., Romette J.L., Ellis J., Zambon M., Peiris M., Goossens H., Reusken C., Koopmans M.P.G., Drosten C. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25 doi: 10.2807/1560-7917.ES.2020.25.3.2000045. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous